• Treating Older AML Patients and Managing Unique Toxicities

  • Jul 20 2022
  • Length: 23 mins
  • Podcast

Treating Older AML Patients and Managing Unique Toxicities

  • Summary

  • Drs Gail Roboz and Courtney DiNardo discuss methods of treating older patients with acute myeloid leukemia and managing unique toxicities.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/964537). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals.

    Resources

    Acute Myeloid Leukemia https://emedicine.medscape.com/article/197802-overview

    Cytarabine https://reference.medscape.com/drug/cytosar-u-depocyt-cytarabine-342089

    Mylotarg (gemtuzumab ozogamicin) https://reference.medscape.com/drug/mylotarg-gemtuzumab-1000186

    A Phase 3 Trial of Azacitidine Versus a Semi-Intensive Fludarabine and Cytarabine Schedule in Older Patients With Untreated Acute Myeloid Leukemia https://pubmed.ncbi.nlm.nih.gov/33626197/

    Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia https://www.nejm.org/doi/full/10.1056/NEJMoa2012971

    Ferrara Criteria https://decisionpoint.medscape.com/oncology/viewarticle/928810

    Hydrea https://reference.medscape.com/drug/droxia-siklos-hydroxyurea-342100

    Mucositis https://emedicine.medscape.com/article/1079570-overview

    Azacytidine https://reference.medscape.com/drug/onureg-vidaza-azacitidine-342263

    Decitabine https://reference.medscape.com/drug/dacogen-decitabine-342091

    Venetoclax https://reference.medscape.com/drug/venclexta-venetoclax-1000078

    Hydroxycarbamide in Combination With Azacitidine or Decitabine Is Antagonistic on DNA Methylation Inhibition https://pubmed.ncbi.nlm.nih.gov/17686055/

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Treating Older AML Patients and Managing Unique Toxicities

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.